K-numberK242943
Device nameQ Switched Nd:YAG Laser machine (QNHF-01)
ApplicantBeijing Nubway S&T Co., Ltd.
Product codeGEX
Device classClass II
Decision dateMar 3, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Q Switched Nd:YAG Laser machine (QNHF-01) is a laser surgical instrument indicated for tattoo removal, treatment of benign vascular lesions, treatment of benign pigmented lesions, and incision, excision, ablation, and vaporization of soft tissue in general dermatology. It delivers laser energy at wavelengths of 1064 nm (for dark inks and pigmented lesions) or 532 nm (for light inks, vascular lesions, and pigmented lesions), with output energy selectable by the physician via a control panel.

Technological characteristics

Both the proposed device and predicate have output wavelengths of 1064 nm and 532 nm with treatment window diameter ranges of 2–10 mm. The proposed device has a pulsewidth of 6 nanoseconds (versus 5 ns for the predicate), a maximum repetition rate of 10 Hz (versus 5 Hz for the predicate), and a maximum 532 nm pulse energy of 260 mJ (versus 250 mJ for the predicate). The device consists of a control panel module, main control module, laser power module, temperature and humidity control module, and laser module.

Test standards cited

IEC 60601-1 Edition 3.2 (general safety and performance), IEC 60601-1-2 Edition 4.1 (electromagnetic compatibility), IEC 60601-2-22 Edition 3.1 (surgical laser equipment), IEC 60825-1 Edition 2.0 (laser safety), ISO 10993-5 (cytotoxicity), ISO 10993-10 (irritation and hypersensitivity), and ISO 10993-23 (irritation tests).

Substantial equivalence argument

The device is substantially equivalent because it has the same indications for use as the predicate device K163123 and shares the same output wavelengths and treatment window ranges. Although the proposed device has minor differences in pulsewidth (1 ns greater), repetition rate (5 Hz greater), and maximum 532 nm pulse energy (10 mJ greater), these differences do not raise new safety or efficacy questions. Non-clinical testing confirmed compliance with relevant medical device standards, and no clinical study was needed because the technological similarities and performance data support substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →